Stay updated on AR101 Long-term Follow-up Study: Clinical Trial
Sign up to get notified when there's something new on the AR101 Long-term Follow-up Study: Clinical Trial page.

Latest updates to the AR101 Long-term Follow-up Study: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record now presents details of the completed Phase 3 AR101 extension study for people with peanut allergy, including its design, eligibility criteria, locations, outcome measures, and results-related information.SummaryDifference87%

- Check19 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.” The study record itself remains a 403 error.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check40 days agoChange DetectedThe error page footer now shows site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record with an access-denied message and making essential study information unavailable.SummaryDifference17%

Stay in the know with updates to AR101 Long-term Follow-up Study: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AR101 Long-term Follow-up Study: Clinical Trial page.